IP Library Granted Patent US 10,590,411
Granted Patent B2
US 10,590,411 · App. 16/297,492 · Granted Mar 17, 2020

Crude biological derivatives competent for nucleic acid detection

Inventors: Brittan Pasloske (Austin, TX); Quoc Hoang (Austin, TX)
Assignee: APPLIED BIOSYSTEMS, LLC
C12N15/1096C12N15/1003C12P19/34C12Q1/6806C12Q2600/158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,590,411
App. No.
16/297,492
Granted
Mar 17, 2020
Kind
B2
Abstract

The invention relates to methods for the detection of a specific sequence of RNA in a cell or tissue sample. The invention also relates to methods to enzymatically manipulate the RNA in a crude cell lysate in a number of applications.

Claims (25)

1. A method for producing cDNA and amplification thereof, from at least one biological unit containing RNA, wherein the biological unit is a cell obtained from cell culture, from a tissue sample or from a body fluid, comprising:

preparing an admixture comprising the biological unit, proteinase K and a deoxyribonuclease;

incubating the admixture under conditions where the proteinase K and deoxyribonuclease are active;

raising the temperature of the admixture containing the active proteinase K and deoxyribonuclease to inactivate the proteinase K and deoxyribonuclease to produce an inactivated admixture; and

carrying out one-step reverse transcription-PCR on the inactivated admixture.

2. The method of claim 1 wherein the deoxyribonuclease is DNase I.

3. The method of claim 1 , wherein the biological unit is a cell obtained from cell culture.

4. The method of claim 1 , wherein the biological unit is a cell obtained from a tissue sample.

5. The method of claim 1 , wherein the biological unit is a eukaryotic cell.

6. The method of claim 5 , wherein the eukaryotic cell is a human cell.

7. The method of claim 1 wherein the biological unit is a prokaryotic cell.

8. The method of claim 1 , wherein the biological unit is a fungal cell.

9. The method of claim 1 wherein the one-step reverse transcription-PCR is one-step real-time reverse transcription-PCR.

10. A method for producing cDNA and amplification thereof for quantification of RNA from at least one biological unit containing RNA, wherein the biological unit is a cell obtained from cell culture, from a tissue sample or from a body fluid, comprising:

preparing an admixture comprising the biological unit, a deoxyribonuclease and at least one catabolic enzyme, wherein said catabolic enzyme is at least proteinase K;

incubating the admixture under conditions where the proteinase K and the deoxyribonuclease are active;

raising the temperature of the admixture to inactivate the proteinase K and deoxyribonuclease to produce an inactivated admixture; and

carrying out one-step reverse transcription-PCR on the inactivated admixture.

11. The method of claim 10 , wherein the biological unit is a cell obtained from cell culture.

12. The method of claim 10 , wherein the biological unit is a cell obtained from a tissue sample.

13. The method of claim 10 , wherein the biological unit is a eukaryotic cell.

14. The method of claim 13 , wherein the eukaryotic cell is a human cell.

15. The method of claim 10 , wherein the biological unit is a prokaryotic cell.

16. The method of claim 10 , wherein the biological unit is a fungal cell.

17. The method of claim 10 wherein the one-step reverse transcription-PCR is one-step real-time reverse transcription-PCR.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2019
From: PASLOSKE, BRITTAN
To: AMBION, INC.
Reel/Frame 050819/0420 →
MERGER Recorded Oct 24, 2019
From: AMBION, INC.
To: APPLERA CORPORATION
Reel/Frame 050819/0660 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2019
From: HOANG, QUOC
To: APPLERA CORPORATION
Reel/Frame 050819/0733 →
MERGER Recorded Oct 24, 2019
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 050819/0916 →
MERGER Recorded Oct 24, 2019
From: ATOM ACQUISITION CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 050819/0994 →
MERGER Recorded Oct 24, 2019
From: ATOM ACQUISITION, LLC & APPLIED BIOSYSTEMS, INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 050820/0295 →
Continuity (6)
Continuation 16001279 · Jun 6, 2018
Continuation 15466824 · Mar 22, 2017
Continuation 13463624 · May 3, 2012
Continuation 10352806 · Jan 28, 2003
Provisional Application 60352402 · Jan 28, 2002
Related Publication 20190270988A1 · Sep 5, 2019